Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
I came across this study. This medication has been proven efficient for migraines and for sound sensitivity which is part of migraine attacks. The medicine is already EMA/FDA approved. The Phase IV study specifically marks hyperacusis as tag for the study, and targets phonophobia together with migraines. Phonophobia here is not described as anxiety for sound as we might define it but as higher sensitivity to sensory stimuli, such as uncomfort of utensils clanking together etc. Hence the hyperacusis tag. They seem to go hand in hand.
Are the mechanisms of migraine induced 'hyperacusis/phonophobia' different from "auditory gain" hyperacusis? Is there a chance this can help general phonophobia/hearing sensitivity too? Here is a study clearly showing decrease in audio sensitivity/phonophobia against placebo:
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
I came across this study. This medication has been proven efficient for migraines and for sound sensitivity which is part of migraine attacks. The medicine is already EMA/FDA approved. The Phase IV study specifically marks hyperacusis as tag for the study, and targets phonophobia together with migraines. Phonophobia here is not described as anxiety for sound as we might define it but as higher sensitivity to sensory stimuli, such as uncomfort of utensils clanking together etc. Hence the hyperacusis tag. They seem to go hand in hand.
Are the mechanisms of migraine induced 'hyperacusis/phonophobia' different from "auditory gain" hyperacusis? Is there a chance this can help general phonophobia/hearing sensitivity too? Here is a study clearly showing decrease in audio sensitivity/phonophobia against placebo:
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine